Marlin Midstream Partners LP (FISH) Financials Nov 14,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Marlin Midstream Partners LP (FISH) Financials Nov 14, 2014, 3:59 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Marlin Midstream Partners LP


Fiscal year is January-December. All values USD millions. 2011 2012 2013 5-year trend
Sales/Revenue - - 65.82M 51.05M 52.86M
Cost of Goods Sold (COGS) incl. D&A - - 46.14M 45.21M 38.09M
COGS excluding D&A - - 40.78M 37.52M 29.89M
Depreciation & Amortization Expense - - 5.37M 7.69M 8.2M
Depreciation - - 5.37M 7.69M 8.2M
Amortization of Intangibles - - 0 0 0
Gross Income - - 19.68M 5.84M 14.77M
2011 2012 2013 5-year trend
SG&A Expense - - 4.17M 4.07M 7.89M
Research & Development - - 0 0 -
Other SG&A - - 4.17M 4.07M 7.89M
Other Operating Expense - - 425,000 994,000 1.22M
Unusual Expense - - 2.61M 186,000 0
EBIT after Unusual Expense - - (2.61M) (186,000) 0
Non Operating Income/Expense - - (217,000) 0 (48,000)
Non-Operating Interest Income - - 20,000 23,000 0
Equity in Affiliates (Pretax) - - 0 0 0
Interest Expense - - 3.73M 4.93M 4.35M
Gross Interest Expense - - 4.91M 5.14M 4.58M
Interest Capitalized - - 1.18M 214,000 232,000
Pretax Income - - 8.54M (4.31M) 1.27M
Income Tax - - 0 0 88,000
Income Tax - Current Domestic - - 0 0 -
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 0 -
Income Tax - Deferred Foreign - - 0 0 -
Income Tax Credits - - 0 0 -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - 0 0 5.86M
Consolidated Net Income - - 8.54M (4.31M) 7.05M
Minority Interest Expense - - 0 0 0
Net Income - - 8.54M (4.31M) 7.05M
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - 0 0 0
Net Income After Extraordinaries - - 8.54M (4.31M) 7.05M
Preferred Dividends - - 0 0 0
Net Income Available to Common - - 8.54M (4.31M) 7.05M
EPS (Basic) - - 0.49 (0.25) 0.40
Basic Shares Outstanding - - 17.45M 17.45M 17.45M
EPS (Diluted) - - 0.49 (0.25) 0.40
Diluted Shares Outstanding - - 17.45M 17.45M 17.76M
EBITDA - - 20.45M 8.47M 13.87M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for Block Investors This Spring

Updated Category News Views 119

Investigation By Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently looking into issues concerning Block, Inc. (NASDAQ: SQ). The firm is focusing on claims related to alleged violations of federal securities laws that may have resulted in significant losses for investors. If you have experienced a loss of over $75,000...

Continue Reading
Aviat Networks Faces Scrutiny After Annual Report Delay

Updated Category News Views 85

Investor Concerns Escalate Amid Aviat Networks' Delay in Reporting Aviat Networks, Inc. (NASDAQ: AVNW) is facing a tough situation as its stock price suffered a notable decline, falling by $6.36, or around 26%, during intraday trading on a recent date. This drop followed the company's announcement that it would miss the deadline for filing its financial statements for the...

Continue Reading
Tarsus Pharmaceuticals Prepares to Share Q2 2025 Results

Updated Category News Views 243

Anticipating Tarsus Pharmaceuticals' Financial Report Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to present its financial results for the second quarter of 2025 during a live webcast slated for Wednesday, August 6, 2025. This event will commence at 1:30 p.m. PT and 4:30 p.m. ET, providing a timely update on the company's performance and strategic...

Continue Reading
Country Garden's Stock Recovers After Debt Restructuring Efforts

Updated Category News Views 135

Country Garden’s Stock Trading Resumes with Momentum Recently, shares of Country Garden (HK: 2007), a prominent name in the Chinese property market, saw an impressive rise as trading resumed in Hong Kong after a lengthy suspension of nine months. This rebound came after the company's notable commitment to creating a debt-restructuring plan aimed at appealing to its...

Continue Reading
Unlocking Long-Term Gains: Insights from Dollar Tree's Success

Updated Category News Views 90

Dollar Tree's Remarkable Growth Over Two Decades Over the last 20 years, Dollar Tree (NASDAQ: DLTR) has become a major player in the retail market, demonstrating incredible resilience and expansion. If someone had put $1,000 into Dollar Tree stock two decades ago, that investment would have surged to more than $7,300 today. This change highlights the effectiveness of...

Continue Reading